ALLARD
Timeline
36 events since 2000Board
Capital
Filings
Financial
200020052010201520202025
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed PDFmicro format · 77 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 13 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 21 days before the deadline
2023
changes role from manager to director“La société a pour objet l’exercice de l’art de guérir au sens large et la pratique de la médecine; La médecine…” (deed in French) · holds 6,364 shares · holds 86 shares · General meeting of 03-10-20237 points ▸
- The capital is divided into 6,450 shares
- resigns as manager
- appointed as director
- General meeting of 03-10-2023
- holds 6,364 shares
- holds 86 shares
- Purpose change, “La société a pour objet l’exercice de l’art de guérir au sens large et la pratique de la médecine; La médecine est exercée par chaque médecin actionnaire, au…” (deed in French)
- The deed holds 9 more points.
Annual accounts 2022 filed PDFmicro format · 5 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 31 days late
2021
Highest result from 2006 to 2025 net €63,306 ▲126% The operating result of €91,962 and the net result of €63,306 are both a record.
Liquidity more than triples current ratio 32.25 The current ratio rises from 10.07 to 32.25. Short-term debt falls from €30,109 to €10,287.
Annual accounts 2020 filed PDFmicro format · 3 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 1 day before the deadline
2019
Annual accounts 2018 filed PDFmicro format · 1 day before the deadline
2018
Annual accounts 2017 filed PDFmicro format · on the deadline day
2017
Weakest financial year net €1,696 ▼89.7% The net result drops to €1,696, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2016 filed PDFmicro format · 30 days late
2016
Annual accounts 2015 filed PDFfull format · 30 days late
2015
Equity above €200,000 equity €207,350 ▲7.5% Equity rises from €192,861 to €207,350.
Annual accounts 2014 filed PDFfull format · 28 days late
2014
Annual accounts 2013 filed PDFfull format · on the deadline day
Capital increase of EUROS 141,050 to EUROS 159,600The capital rose from EUROS 18,550 to EUROS 159,600, with 5,700 new shares · Capital contribution: apport des créances prévantées détenues sur la société · holds 740 shares5 points ▸
- holds 740 shares
- holds 10 shares
- Capital increase, euros 141.050
- Capital, euros 159.600, 6,450 shares
- Article 5 of the articles of association amended
- The deed holds 4 more points.
2013
Liquidity doubles current ratio 10.27 The current ratio rises from 5.11 to 10.27. Short-term debt falls from €27,388 to €12,192.
Annual accounts 2012 filed PDFfull format · 29 days late
2012
Equity above €150,000 equity €169,435 ▲17.9% Equity rises from €143,684 to €169,435.
Annual accounts 2011 filed PDFfull format · on the deadline day
2011
Annual accounts 2010 filed PDFfull format · 2 days before the deadline
2010
Annual accounts 2009 filed PDFfull format · 30 days late
2009
Equity above €100,000 equity €106,171 ▲37.2% Equity rises from €77,361 to €106,171.
Annual accounts 2008 filed PDFfull format · 6 days late
2008
Annual accounts 2007 filed PDFfull format · 1 day before the deadline
2007
Annual accounts 2006 filed PDFfull format · 7 days before the deadline
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
2002
Annual accounts 2001 filed PDFfull format
2001
Annual accounts 2000 filed PDFfull format
2000
Incorporation published on 14-03-2000
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank